subscribeSubscribe
Hetero Labs Generic Ertugliflozin Receives Tentative Approval in US

Hetero Labs Generic Ertugliflozin Receives Tentative Approval in US

FDA
17 Apr 2024
Share Share
Zenara`s Generic Ertugliflozin Receives Approval in the U.S.

Zenara`s Generic Ertugliflozin Receives Approval in the U.S.
FDA
04 Apr 2023
Share Share
FDA Confirms Paragraph IV Patent Litigation for Ertugliflozin

FDA Confirms Paragraph IV Patent Litigation for Ertugliflozin
FDA
08 Feb 2022
Share Share
Ertugliflozin Reduces Likelihood of Insulin Initiation in Insulin-Naive Patients

Ertugliflozin Reduces Likelihood of Insulin Initiation in Insulin-Naive Patients
FIRSTWORDPHARMA
29 Jun 2021
Share Share
Merck`s Steglatro shows limited promise with heart failure hospitalization data

Merck`s Steglatro shows limited promise with heart failure hospitalization data
Kyle Blankenship FIERCEPHARMA
31 Aug 2020
Share Share
Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Endpoint

Merck and Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin) Meets Endpoint
PRESS RELEASE
17 Jun 2020
Share Share
ADA: Merck, Pfizer`s Steglatro rings up CV safety win but still lags heart

ADA: Merck, Pfizer`s Steglatro rings up CV safety win but still lags heart
FIERCE PHARMA
17 Jun 2020
Share Share
Steglatro rings up CV safety win but still lags SGLT2 peers

Steglatro rings up CV safety win but still lags SGLT2 peers
Carly Helfand FIERCE PHARMA
16 Jun 2020
Share Share
NICE recommendation for Steglatro in type II diabetes

NICE recommendation for Steglatro in type II diabetes
Anna Smith PHARMA TIMES
28 Mar 2019
Share Share
Diabetes drugs in SGLT2 inhibitor class linked to pancreatitis genital infection

Diabetes drugs in SGLT2 inhibitor class linked to pancreatitis genital infection
PHARMABIZ
27 Mar 2019
Share Share